Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study.
Dan XuYing YangZhao YinSanfang TuDanian NieYiqing LiZhenqian HuangQixin SunChangfen HuangXiaqi NieZurong YaoPengcheng ShiYu ZhangXuejie JiangQi-Fa LiuGuo-Pan YuPublished in: Blood cancer journal (2023)